PRINCIPAL SHAREHOLDERS AGREEMENT by and among Ortho Clinical Diagnostics Holdings plc andPrincipal Shareholders Agreement • March 19th, 2021 • Ortho Clinical Diagnostics Holdings PLC • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledMarch 19th, 2021 Company Industry JurisdictionThis Principal Shareholders Agreement (this “Agreement”) is made as of January 25, 2021 by and among Ortho Clinical Diagnostics Holdings plc, a public limited company incorporated and registered in England and Wales (the “Company”), and Carlyle Partners VI Cayman Holdings, L.P., a Cayman Islands exempted limited partnership (the “Initial Carlyle Shareholder”), and any other shareholder who from time to time becomes party to this Agreement by execution of a joinder agreement substantially in the form of Exhibit A (a “Joinder Agreement”).
FORM OF PRINCIPAL SHAREHOLDERS AGREEMENT BY AND AMONG ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC AND THE CARLYLE SHAREHOLDERPrincipal Shareholders Agreement • January 4th, 2021 • Ortho Clinical Diagnostics Holdings PLC • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledJanuary 4th, 2021 Company Industry JurisdictionThis Principal Shareholders Agreement (this “Agreement”) is made as of [ ● ], 2021 by and among Ortho Clinical Diagnostics Holdings plc, a public limited company incorporated and registered in England and Wales (the “Company”), and Carlyle Partners VI Cayman Holdings, L.P., a Cayman Islands exempted limited partnership (the “Initial Carlyle Shareholder”), and any other shareholder who from time to time becomes party to this Agreement by execution of a joinder agreement substantially in the form of Exhibit A (a “Joinder Agreement”).